Necrotizing fasciitis is a severe and rapidly progressive soft tissue infection characterized by necrosis of the muscle fascia and subcutaneous tissues. This aggressive condition often spreads along fascial planes, areas with limited blood supply, while initially sparing the overlying skin. This deceptive presentation can lead to delayed diagnosis and surgical intervention, significantly impacting patient outcomes. Understanding the nuances of necrotizing fasciitis diagnosis is critical for healthcare professionals. This article provides an in-depth review of the evaluation, treatment, and prognosis of necrotizing fasciitis, emphasizing the crucial role of prompt and accurate diagnosis in improving patient care.
Understanding Necrotizing Fasciitis
Necrotizing fasciitis, often referred to as a “flesh-eating” infection, is a life-threatening condition requiring immediate medical attention. It’s essential to recognize that necrotizing fasciitis is not a single disease entity but rather a subset of severe skin and soft tissue infections. The infection’s rapid progression and ability to cause extensive tissue destruction underscore the importance of early and accurate diagnosis. Necrotizing fasciitis can arise from various sources, including post-surgical complications, invasive procedures, or even seemingly minor breaches in skin integrity like phlebotomy. The causative agents are typically polymicrobial, often involving gas-producing bacteria, as seen in Image 1.
Etiology and Risk Factors
The development of necrotizing fasciitis is usually an acute process, unfolding rapidly over a few days. In approximately 80% of cases, bacterial infection directly enters through compromised skin. While various bacteria can be involved, Gram-positive cocci, particularly Staphylococcus aureus and Streptococcus strains, are frequently implicated in single-site infections. Polymicrobial infections, involving a mix of gram-negative and anaerobic bacteria, are also common. Certain patient populations are at increased risk of developing necrotizing fasciitis. Diabetes mellitus and chronic alcoholism are significant predisposing factors. Liver cirrhosis also elevates susceptibility to this severe infection.
Epidemiology of Necrotizing Fasciitis
Necrotizing fasciitis is a relatively rare but serious condition. In the United States, the annual incidence is estimated at about 0.4 cases per 100,000 people. However, in certain geographical areas, the incidence can be as high as 1 in 100,000 individuals, highlighting regional variations in occurrence.
Pathophysiology: The Progression of Infection
The infection in necrotizing fasciitis aggressively targets the muscle fascia. Initially, the overlying skin may appear deceptively normal, delaying suspicion of the underlying severity. Over several days, the skin undergoes noticeable changes, transitioning to an erythematous, reddish-purple, or bluish-gray discoloration. The texture of the skin becomes indurated, swollen, shiny, and warm to the touch. At this stage, a hallmark diagnostic sign is exquisite tenderness to palpation, often disproportionate to the initial visible symptoms. Pain, similarly, can be intense and out of proportion to the apparent skin findings.
Skin breakdown typically begins within 3 to 5 days, accompanied by the formation of bullae and cutaneous gangrene. Paradoxically, pain may decrease in the affected area due to thrombosis of small blood vessels and destruction of superficial nerves in the subcutaneous tissues. As the infection progresses to advanced stages, systemic symptoms emerge, including fever, tachycardia, and sepsis, indicating widespread systemic involvement. The bacterial flora involved in necrotizing fasciitis is often complex, with anaerobic bacteria frequently mixed with aerobic organisms. Common aerobic bacteria include Clostridium, Bacteroides, coliforms, Proteus, Klebsiella, Peptostreptococcus, and Pseudomonas. These pathogens rapidly spread along subcutaneous tissues and deep fascial planes, leading to vascular occlusion, tissue necrosis, and ischemia, driving the destructive nature of the infection.
Histopathological Findings
Histopathological examination of tissue obtained during surgical debridement provides crucial diagnostic confirmation. Typically, specimens reveal extensive necrosis of the superficial fascia. Small and medium-sized blood vessels within the affected tissue are often thrombosed. Microscopic examination shows aggregates of neutrophils in the fascia and subcutaneous tissues, indicative of an intense inflammatory response. Small vessel vasculitis and extensive fat necrosis are also characteristic features. Necrosis extends to the glands within the dermis and subcutaneous tissues. Gram staining of tissue samples reveals a mixed population of microorganisms, reflecting the polymicrobial nature of many necrotizing fasciitis cases.
History and Physical Examination: Clues to Diagnosis
Clinical suspicion is paramount in the early diagnosis of necrotizing fasciitis. A key diagnostic clue is pain that is disproportionately severe compared to the apparent skin findings. Patients often present with excruciating pain that seems excessive for the visible signs of infection. Systemic septic signs, such as fever, tachycardia, and hypotension, are also more common in necrotizing infections compared to non-necrotizing infections. Physical examination findings suggestive of necrotizing soft tissue infections include tenderness extending beyond the erythematous border of the affected area, crepitus (a crackling sensation due to gas in tissues), and cellulitis. The presence of bullae, ecchymotic skin changes, dysesthesia (abnormal sensation), or paresthesia (numbness or tingling) should raise strong suspicion for necrotizing infection. Subcutaneous emphysema and crepitus are almost always present and are highly suggestive findings. Anesthesia in certain areas, due to nerve fiber damage, can also be observed. Given the rapid spread of infection, suspicion for necrotizing fasciitis should be high in cases of intense, unexplained pain associated with skin and soft tissue infection.
Evaluation and Diagnostic Tools
Prompt and aggressive management is crucial for any rapidly progressing skin or soft tissue infection due to the challenges in differentiating necrotizing from non-necrotizing infections in the early stages. The Laboratory Risk Indicator for Necrotizing Infection (LRINEC) score was developed to aid in distinguishing necrotizing soft tissue infections (NSTIs) from other severe soft tissue infections. This scoring system, developed in 2004, is based on abnormalities in six independent laboratory variables:
LRINEC Scoring System:
- C-reactive protein (CRP), mg/L:
- <150: 0 points
- >150: 4 points
- Total white cell count (WBC), cells/mm³:
- <15,000: 0 points
- 15,000 to 25,000: 1 point
- >25,000: 2 points
- Hemoglobin, g/dL:
- >13.5: 0 points
- 11 to 13.5: 1 point
- <11: 2 points
- Sodium, mmol/L:
- ≥135: 0 points
- <135: 2 points
- Creatinine, mg/dL:
- ≤1.6: 0 points
- >1.6: 2 points
- Glucose, mg/dL:
- ≤180: 0 points
- >180: 1 point
A LRINEC score of 6 or greater has a positive predictive value of 92% and a negative predictive value of 96% for necrotizing infection. A score of 8 or higher indicates a 75% risk of necrotizing infection. While the LRINEC score can be a helpful adjunct, it’s important to emphasize that the diagnosis of NSTIs remains primarily clinical. Imaging modalities can provide valuable supportive data when the diagnosis is uncertain. Plain film radiography may reveal soft tissue thickening and opacity, similar to cellulitis. Computed tomography (CT) scans are more sensitive than plain films in identifying necrotizing soft tissue infections and can detect gas in the soft tissues, a characteristic feature. However, plain X-rays alone are not diagnostically reliable for necrotizing fasciitis.
In cases of diagnostic uncertainty, a “finger test” or surgical exploration under local anesthesia can be performed. This involves probing the affected area with a finger to assess tissue planes. In necrotizing fasciitis, the necrotic tissue typically offers minimal resistance to blunt dissection along fascial planes. Aspiration of fluid from the affected area for Gram stain and culture can also be performed to identify causative organisms. Bedside B-mode color Doppler ultrasound can be a valuable tool for early diagnosis, assessing blood flow and tissue characteristics. Crucially, no laboratory or imaging test should delay surgical intervention if necrotizing fasciitis is clinically suspected. Prompt surgical exploration and debridement are paramount.
Treatment and Management Strategies
Patients with suspected necrotizing fasciitis require immediate transfer to the intensive care unit (ICU). Sepsis associated with necrotizing fasciitis often leads to refractory hypotension and diffuse capillary leak, necessitating aggressive resuscitation with intravenous fluids and vasopressors (inotropes) to maintain blood pressure. Patients should be kept NPO (nothing per oral) until surgical evaluation. Nutritional support is vital but should commence post-operatively. Enteral feeding should be initiated as soon as the patient is hemodynamically stable to mitigate the significant negative protein balance due to catabolism.
Key principles in the treatment and management of necrotizing fasciitis and other skin and soft-tissue infections include:
- Early Diagnosis and Differentiation: Promptly distinguish between necrotizing and non-necrotizing infections.
- Empiric Antibiotic Therapy: Initiate broad-spectrum antibacterial coverage immediately.
- Source Control: Aggressively control the source of infection through surgical drainage of abscesses and debridement of necrotic tissue in NSTIs.
- Pathogen Identification and Targeted Therapy: Identify causative pathogens and adjust antimicrobial therapy accordingly based on culture and sensitivity results.
Empiric antimicrobial regimens for necrotizing fasciitis typically include broad-spectrum agents to cover a wide range of potential pathogens. Examples of antibiotic combinations include:
- Imipenem 1 g every 6 to 8 hours, daptomycin 6 mg/kg QD, and clindamycin 600 mg to 900 mg four times daily.
- Piperacillin/tazobactam 3.375 g every 6 hours or 4.5 g every 8 hours, daptomycin 6 mg/kg QD, and clindamycin 600 mg to 900 mg four times daily.
- Meropenem 1 g IV every 8 hours, vancomycin 15 to 20 mg/kg/dose every 8 to 12 hours, and clindamycin 600 mg to 900 mg four times daily.
Surgical Intervention: The Cornerstone of Treatment
Surgery is the definitive treatment for necrotizing fasciitis. Surgical consultation should be obtained immediately, and no time should be wasted in proceeding with surgery. Early surgical intervention is directly correlated with improved patient outcomes. Surgery involves extensive, wide debridement of all necrotic tissues. In some cases, a planned second-look surgery may be necessary to ensure complete removal of devitalized tissue. Early and aggressive surgical debridement can minimize tissue loss and potentially prevent limb amputation in cases of extremity involvement. Following wide debridement, wounds are typically left open and packed with wet gauze. Daily dressing changes are essential. Patient recovery is significantly enhanced when necrotic tissue is promptly removed. Surgical judgment is crucial in determining the extent of debridement, particularly when encountering tissue that appears normal but may be non-viable. In cases of doubt, it’s generally safer to err on the side of more extensive debridement to ensure removal of all infected tissue. Hemodynamic stability often improves significantly after removal of necrotic tissue and pus. Patients typically require intubation and continued monitoring in the ICU post-operatively. Daily surgical debridement may be necessary in some individuals. Meticulous hemostasis is critical during surgery. Repeated surgical procedures may be required to achieve complete debridement.
Soft Tissue Reconstruction
Once all necrotic tissue has been removed and granulation tissue is evident, a plastic surgeon should be consulted for soft tissue reconstruction. Primary wound closure is often not feasible due to the extent of tissue loss. Reconstruction may involve muscle flaps to provide coverage and wound closure. If insufficient natural skin is available for skin grafting, artificial skin substitutes may be utilized. Hyperbaric oxygen therapy is another adjunctive treatment modality that may be considered. While some literature suggests potential benefits, logistical challenges in transporting critically ill ICU patients to hyperbaric oxygen facilities may limit its widespread use. Hyperbaric oxygen therapy may be more effective for smaller wounds but lacks robust evidence of improved healing or survival in large necrotizing fasciitis wounds. It’s crucial to recognize that hyperbaric oxygen therapy is an adjunct and not a substitute for surgical debridement. It may be considered in stable patients as a complementary treatment and some data suggest it may contribute to reduced mortality.
Differential Diagnosis
The differential diagnosis for necrotizing fasciitis includes several other conditions that may present with similar symptoms:
- Cellulitis
- Epididymitis
- Gas gangrene
- Orchitis
- Testicular torsion
- Toxic shock syndrome
Prognosis and Complications
Necrotizing fasciitis is a severe, life-threatening infection with significant mortality rates, ranging from 20% to 80%. Factors associated with poor prognosis include infection with specific streptococcal strains, advanced age, uncontrolled diabetes, immunosuppression, and delayed surgical intervention. Even among survivors, recovery is often prolonged, with significant functional deficits. Complications of necrotizing fasciitis can be severe and include:
- Multiorgan failure
- Septic shock
- Limb loss
- Severe scarring
- Toxic shock syndrome
- Death
Pearls and Key Considerations
Necrotizing fasciitis remains a highly lethal condition. Key risk factors for adverse outcomes include advanced age, infection with resistant organisms, delays in diagnosis and treatment, multiorgan failure, and the site of infection.
Enhancing Healthcare Team Outcomes
Optimal management of necrotizing fasciitis requires a multidisciplinary healthcare team approach. This team ideally includes specialists such as a general surgeon, infectious disease expert, intensivist, nephrologist, critical care nurses, radiologist, urologist (depending on the site of infection), and wound care specialists. The nurse and pharmacist play critical roles. Nurses are often the first to recognize subtle signs of deterioration or disproportionate pain. Prompt surgical consultation is essential. Pharmacists ensure appropriate antibiotic selection based on culture results and antimicrobial stewardship principles. Patients should be kept NPO, hydrated, and promptly started on broad-spectrum antibiotics. Stoma nurses may be needed for fecal diversion in perineal infections. ICU management is crucial until signs of systemic toxicity resolve. Wound care nurses are essential for managing large open wounds requiring prolonged dressing changes and potentially reconstructive surgery. Collaborative, coordinated care is paramount to improve outcomes and reduce mortality in necrotizing fasciitis.
Outcomes and Long-Term Considerations
Necrotizing fasciitis carries a significant mortality risk, ranging from 30% to 90%, influenced by patient factors, the causative organism, and the timeliness of diagnosis and treatment. Specific streptococcal strains are associated with particularly poor prognosis. Other factors negatively impacting prognosis include loss of consciousness, respiratory distress, renal failure, and ARDS (acute respiratory distress syndrome). Survival is maximized with immediate radical debridement, aggressive hydration, and broad-spectrum antibiotics. However, even survivors may experience a reduced lifespan compared to age-matched individuals, highlighting the long-term impact of this severe infection.
Review Questions
Figure 1: Necrotizing Fasciitis. The appearance of the lower leg after serial debridements of skin and fascia.
References
1.Kim YH, Ha JH, Kim JT, Kim SW. Managing necrotising fasciitis to reduce mortality and increase limb salvage. J Wound Care. 2018 Sep 01;27(Sup9a):S20-S27. [PubMed: 30207851]
2.Lange JH, Cegolon L. Comment on: Early clinical manifestations of vibrio necrotising fasciitis. Singapore Med J. 2018 Aug;59(8):449. [PMC free article: PMC6109835] [PubMed: 30175372]
3.Heijkoop B, Parker N, Spernat D. Fournier’s gangrene: not as lethal as previously thought? A case series. ANZ J Surg. 2019 Apr;89(4):350-352. [PubMed: 30173412]
4.Erichsen Andersson A, Egerod I, Knudsen VE, Fagerdahl AM. Signs, symptoms and diagnosis of necrotizing fasciitis experienced by survivors and family: a qualitative Nordic multi-center study. BMC Infect Dis. 2018 Aug 28;18(1):429. [PMC free article: PMC6114743] [PubMed: 30153808]
5.Khalid M, Junejo S, Mir F. Invasive Community Acquired Methicillin-Resistant Staphylococcal Aureus (CA-MRSA) Infections in Children. J Coll Physicians Surg Pak. 2018 Sep;28(9):S174-S177. [PubMed: 30173689]
6.Fernando SM, Tran A, Cheng W, Rochwerg B, Kyeremanteng K, Seely AJE, Inaba K, Perry JJ. Necrotizing Soft Tissue Infection: Diagnostic Accuracy of Physical Examination, Imaging, and LRINEC Score: A Systematic Review and Meta-Analysis. Ann Surg. 2019 Jan;269(1):58-65. [PubMed: 29672405]
7.Fais P, Viero A, Viel G, Giordano R, Raniero D, Kusstatscher S, Giraudo C, Cecchetto G, Montisci M. Necrotizing fasciitis: case series and review of the literature on clinical and medico-legal diagnostic challenges. Int J Legal Med. 2018 Sep;132(5):1357-1366. [PubMed: 29627916]
8.Yaşar NF, Uylaş MU, Badak B, Bilge U, Öner S, İhtiyar E, Çağa T, Paşaoğlu E. Can we predict mortality in patients with necrotizing fasciitis using conventional scoring systems? Ulus Travma Acil Cerrahi Derg. 2017 Sep;23(5):383-388. [PubMed: 29052823]
9.Ballesteros-Betancourt JR, García-Tarriño R, Ríos-Guillermo J, Rodriguez-Roiz JM, Camacho P, Zumbado-Dijeres A, Domingo-Trepat A, Llusá-Pérez M, Combalia-Aleu A, García-Ramiro S, Soriano-Viladomiu A. Necrotizing fasciitis attended in the Emergency Department in a tertiary Hospital: Evaluation of the LRINEC scale. Rev Esp Cir Ortop Traumatol. 2017 Jul-Aug;61(4):265-272. [PubMed: 28641951]
10.Bonne SL, Kadri SS. Evaluation and Management of Necrotizing Soft Tissue Infections. Infect Dis Clin North Am. 2017 Sep;31(3):497-511. [PMC free article: PMC5656282] [PubMed: 28779832]
11.Semenič D, Kolar P. Fournier’s Gangrene Does Not Spare Young Adults. Wounds. 2018 Jul;30(7):E73-E76. [PubMed: 30059341]
12.Abass-Shereef J, Kovacs M, Simon EL. Fournier’s Gangrene Masking as Perineal and Scrotal Cellulitis. Am J Emerg Med. 2018 Sep;36(9):1719.e1-1719.e2. [PubMed: 30041909]
13.Baraket O, Triki W, Ayed K, Hmida SB, Lahmidi MA, Baccar A, Bouchoucha S. [Therapeutic factors affecting the healing process in patients with gangrene of the perineum]. Pan Afr Med J. 2018;29:70. [PMC free article: PMC5987071] [PubMed: 29875951]
14.Ioannidis O, Kitsikosta L, Tatsis D, Skandalos I, Cheva A, Gkioti A, Varnalidis I, Symeonidis S, Savvala NA, Parpoudi S, Paraskevas GK, Pramateftakis MG, Kotidis E, Mantzoros I, Tsalis KG. Fournier’s Gangrene: Lessons Learned from Multimodal and Multidisciplinary Management of Perineal Necrotizing Fasciitis. Front Surg. 2017;4:36. [PMC free article: PMC5502266] [PubMed: 28740847]
15.Ray-Zack MD, Hernandez MC, Younis M, Hoch WB, Soukup DS, Haddad NN, Zielinski MD. Validation of the American Association for the Surgery of Trauma emergency general surgery grade for skin and soft tissue infection. J Trauma Acute Care Surg. 2018 Jun;84(6):939-945. [PubMed: 29794690]
16.Gawaziuk JP, Strazar R, Cristall N, Logsetty S. Factors predicting health-related quality of life following necrotizing fasciitis. J Plast Reconstr Aesthet Surg. 2018 Jun;71(6):857-862. [PubMed: 29503165]
Disclosures: Heather Wallace declares no relevant financial relationships with ineligible companies.
Disclosures: Thomas Perera declares no relevant financial relationships with ineligible companies.
